Soleno Therapeutics (SLNO) is down -26.7%, or -$17.06 to $46.79.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLNO:
- Soleno Therapeutics price target lowered to $106 from $123 at Wells Fargo
- Soleno Therapeutics Achieves Profitability with VYKAT XR Launch
- Soleno Therapeutics: Strong Sales Growth and Profitability Drive Buy Rating
- Closing Bell Movers: AMD falls 4% on earnings, Trex, Pinterest down sharply
- Soleno Therapeutics reports Q3 EPS 47c, consensus 6c